Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Regulated Product Review Process	NCIT_C54697
Premarket Review	NCIT_C54698	[The examination of data and information in an application for premarket review described in sections 505, 510(k), 513(f), 515, or 520(g) or 520(l) of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act of data and information contained in any investigational new drug application, investigational device exemption, new drug application, biologics license application, device premarket notification, device reclassification petition, and premarket approval application.]
Market Withdrawal	NCIT_C54699	[A removal or correction by manufacturer or owner of a marketed product that the FDA considers to be either no violation or in minor violation of the laws it administers, and against which the agency would not initiate legal action. The concept does not refer to redemption or liquidation of stocks issued by the company.]
Mucinous Tall Columnar Adenocarcinoma Cell	NCIT_C54690
Adenocarcinoma Cell with Intracytoplasmic Mucin	NCIT_C37117
Invasive Lobular Breast Carcinoma, Signet Ring Variant	NCIT_C54691	[An invasive lobular carcinoma characterized by the presence of malignant epithelial cells with large intracytoplasmic lumina that cause displacement of the nuclei towards one pole of the cells.]
Invasive Lobular Breast Carcinoma	NCIT_C7950	[An infiltrating lobular adenocarcinoma of the breast. The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma. The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.]
Signet Ring Cell Breast Carcinoma	NCIT_C5175	[An invasive breast adenocarcinoma characterized by the presence of malignant epithelial cells with signet ring appearance.]
Tumor Replacement	NCIT_C54692	[The process whereby normal tissue cells and structures are replaced by tumor cells.]
Medical Product Document	NCIT_C54693	[A document defining content and form of the information that has to be supplied with or about a medical product by or on behalf of the marketing authorization holder.]
Labeling	NCIT_C54694	[All written, printed, or graphic matter accompanying an article at any time while such article is in interstate commerce or held for sale after shipment or delivery in interstate commerce.]
8q11-q12	NCIT_C40044	[A chromosome band present on 8q]
15q23-q24	NCIT_C40045	[A chromosome band present on 15q]
8q21-q22	NCIT_C40046	[A chromosome band present on 8q]
10q24.3	NCIT_C40047	[A chromosome band present on 10q]
12q13.1-q13.3	NCIT_C40048	[A chromosome band present on 12q]
CYP2B6 Gene	NCIT_C40049	[This gene is involved in the oxidation of both endogenous substrates and drugs/xenobiotics.]
Malignant Ovarian Endometrioid Tumor	NCIT_C40051	[An invasive malignant neoplasm that arises from the ovary characterized by the presence of malignant, endometrial-type cells. It includes endometrioid adenocarcinoma and carcinosarcoma.]
Ovarian Endometrioid Tumor	NCIT_C6257	[A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of glands and/or cysts lined by neoplastic cells that resemble endometrial cells.]
CYP7A1 Gene	NCIT_C40052	[This gene is involved in bile acid synthesis and steroid metabolism.]